Table 3 Hazard ratios for psychotropic medication purchases according to joint association of physical activity and BMI
All | Model 1 | Model 2 | Model 3 | Model 4 |
Highly active normal-weight | 1.00 | 1.00 | 1.00 | 1.00 |
Moderately active normal-weight | 1.17 (1.01–1.35) | 1.15 (0.99–1.33) | 1.15 (0.99–1.33) | 1.09 (0.94–1.26) |
Inactive normal-weight | 1.28 (1.07–1.53) | 1.21 (1.01–1.44) | 1.20 (1.04–1.44) | 1.15 (0.96–1.37) |
Highly active overweight | 1.01 (0.85–1.19) | 1.00 (0.85–1.18) | 1.01 (0.85–1.19) | 0.96 (0.82–1.14) |
Moderately active overweight | 1.27 (1.10–1.48) | 1.15 (0.99–1.34) | 1.15 (0.99–1.34) | 1.08 (0.93–1.26) |
Inactive overweight | 1.41 (1.20–1.65) | 1.38 (1.18–1.62) | 1.37 (1.17–1.61) | 1.21 (1.04–1.42) |
Antidepressants | Model 1 | Model 2 | Model 3 | Model 4 |
Highly active normal-weight | 1.00 | 1.00 | 1.00 | 1.00 |
Moderately active normal-weight | 1.21 (1.01–1.45) | 1.21 (1.01–1.44) | 1.20 (1.00–1.43) | 1.15 (0.97–1.38) |
Inactive normal-weight | 1.45 (1.17–1.79) | 1.38 (1.12–1.71) | 1.37 (1.11–1.67) | 1.31 (1.06–1.63) |
Highly active overweight | 1.06 (0.86–1.29) | 1.06 (0.87–1.30) | 1.07 (0.87–1.31) | 1.03 (0.84–1.25) |
Moderately active overweight | 1.39 (1.16–1.66) | 1.25 (1.05–1.50) | 1.26 (1.05–1.51) | 1.19 (1.00–1.43) |
Inactive overweight | 1.59 (1.32–1.91) | 1.55 (1.29–1.87) | 1.53 (1.27–1.85) | 1.36 (1.13–1.64) |
Sedatives | Model 1 | Model 2 | Model 3 | Model 4 |
Highly active normal-weight | 1.00 | 1.00 | 1.00 | 1.00 |
Moderately active normal-weight | 1.20 (1.00–1.44) | 1.19 (0.99–1.43) | 1.18 (0.99–1.42) | 1.15 (0.95–1.38) |
Inactive normal-weight | 1.24 (0.99–1.56) | 1.15 (0.91–1.44) | 1.14 (0.91–1.43) | 1.09 (0.87–1.37) |
Highly active overweight | 0.99 (0.80–1.21) | 0.94 (0.76–1.16) | 0.96 (0.78–1.18) | 0.93 (0.76–1.15) |
Moderately active overweight | 1.23 (1.02–1.47) | 1.12 (0.93–1.35) | 1.13 (0.93–1.36) | 1.05 (0.87–1.27) |
Inactive overweight | 1.32 (1.08–1.61) | 1.28 (1.05–1.56) | 1.27 (1.04–1.55) | 1.14 (0.93–1.39) |